Sen. Elizabeth Warren (D-Mass.) is urging the Federal Trade Commission to scrutinize recent deals from McKesson and Cardinal Health to buy oncology practices, saying those transactions pose “clear, anticompetitive risks.” The letter from Warren to the FTC highlights how prominent lawmakers continue to support the Biden administration’s antitrust agencies, which have put health care mergers in their crosshairs. The Department of Justice, for example, has created a task force specifically to “identify and root out monopolies and collusive practices” within the health care industry, to the dismay of companies and the investment banks that advise them.
Read the full article: Warren Wants Close FTC Scrutiny of Drug Distributors Buying Cancer Medical Groups //
Source: https://www.statnews.com/2024/10/29/cancer-care-mckesson-cardinal-health-ftc-elizabeth-warren/